{"count": 123, "results": [{"_id": "35674192", "pmid": 35674192, "pmcid": "PMC9278574", "title": "Comparative efficacy of generic nifedipine versus brand-name amlodipine for hypertension management in Taiwan", "journal": "J Clin Hypertens (Greenwich)", "authors": ["Lee HW", "Huang CC", "Leu HB", "Lin YJ"], "date": "2022-07-01T00:00:00Z", "doi": "10.1111/jch.14521", "meta_date_publication": "2022 Jul", "meta_volume": "24", "meta_issue": "7", "meta_pages": "870-877", "score": 50269.88, "text_hl": "Cox regression analysis revealed that @CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@nifedipine@@@ CYH and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Norvasc@@@ had similar efficacy in terms of 3P-@<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@MACE@@@ (hazard ratio, 0.970; 95% confidence interval, 0.601-1.565, P = .900) and 4P-@<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@MACE@@@ (hazard ratio, 0.880; 95% confidence interval, 0.628-1.233, P = .459). ", "citations": {"NLM": "Lee HW, Huang CC, Leu HB, Lin YJ. Comparative efficacy of generic nifedipine versus brand-name amlodipine for hypertension management in Taiwan J Clin Hypertens (Greenwich). 2022 Jul;24(7):870-877. PMID: 35674192", "BibTeX": "@article{35674192, title={Comparative efficacy of generic nifedipine versus brand-name amlodipine for hypertension management in Taiwan}, author={Lee HW and Huang CC and Leu HB and Lin YJ}, journal={J Clin Hypertens (Greenwich)}, volume={24}, number={7}, pages={870-877}}"}}, {"_id": "37138666", "pmid": 37138666, "pmcid": "PMC10151143", "title": "Investigation of the Effects of Some Cardiovascular Drugs on Angiogenesis by Transgenic Zebrafish", "journal": "Mediators Inflamm", "authors": ["Lv H", "Liu B", "Qin Y"], "date": "2023-04-24T00:00:00Z", "doi": "10.1155/2023/1958046", "meta_date_publication": "2023", "meta_volume": "2023", "meta_issue": "", "meta_pages": "1958046", "score": 50266.074, "text_hl": "...@<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@CVD@@@:", "citations": {"NLM": "Lv H, Liu B, Qin Y. Investigation of the Effects of Some Cardiovascular Drugs on Angiogenesis by Transgenic Zebrafish Mediators Inflamm. 2023;2023():1958046. PMID: 37138666", "BibTeX": "@article{37138666, title={Investigation of the Effects of Some Cardiovascular Drugs on Angiogenesis by Transgenic Zebrafish}, author={Lv H and Liu B and Qin Y}, journal={Mediators Inflamm}, volume={2023}, pages={1958046}}"}}, {"_id": "39589752", "pmid": 39589752, "title": "Comparative Effectiveness of Lercanidipine and Amlodipine on Major Adverse Cardiovascular Events in Hypertensive Patients.", "journal": "Am J Hypertens", "authors": ["Jeon J", "Ryoo S", "Oh S", "Hong SJ", "Yu CW", "Kim YH", "Kim EJ", "Joo HJ"], "date": "2024-11-26T00:00:00Z", "doi": "10.1093/ajh/hpae147", "meta_date_publication": "2024 Nov 26", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50258.926, "text_hl": "Comparative Effectiveness of @CHEMICAL_lercanidipine @CHEMICAL_MESH:C060343 @@@Lercanidipine@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ on Major @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@Adverse Cardiovascular Events@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertensive@@@ @SPECIES_9606 @@@Patients@@@.", "citations": {"NLM": "Jeon J, Ryoo S, Oh S, Hong SJ, Yu CW, Kim YH, Kim EJ, Joo HJ. Comparative Effectiveness of Lercanidipine and Amlodipine on Major Adverse Cardiovascular Events in Hypertensive Patients. Am J Hypertens. 2024 Nov 26;():. PMID: 39589752", "BibTeX": "@article{39589752, title={Comparative Effectiveness of Lercanidipine and Amlodipine on Major Adverse Cardiovascular Events in Hypertensive Patients.}, author={Jeon J and Ryoo S and Oh S and Hong SJ and Yu CW and Kim YH and Kim EJ and Joo HJ}, journal={Am J Hypertens}}"}}, {"_id": "32638928", "pmid": 32638928, "title": "Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases.", "journal": "Rev Bras Enferm", "authors": ["Palma Sobrinho ND", "Campos JF", "Silva RCD"], "date": "2020-01-01T00:00:00Z", "doi": "10.1590/0034-7167-2019-0307", "meta_date_publication": "2020", "meta_volume": "73", "meta_issue": "5", "meta_pages": "e20190307", "score": 50253.715, "text_hl": "Drug scheduling by nurses and drug interactions in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@.", "citations": {"NLM": "Palma Sobrinho ND, Campos JF, Silva RCD. Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases. Rev Bras Enferm. 2020;73(5):e20190307. PMID: 32638928", "BibTeX": "@article{32638928, title={Drug scheduling by nurses and drug interactions in patients with cardiovascular diseases.}, author={Palma Sobrinho ND and Campos JF and Silva RCD}, journal={Rev Bras Enferm}, volume={73}, number={5}, pages={e20190307}}"}}, {"_id": "34934496", "pmid": 34934496, "pmcid": "PMC8650752", "title": "Hyperinsulinemia/euglycemia and intravenous lipid emulsion therapy for the management of severe amlodipine toxicosis in a cat", "journal": "Clin Case Rep", "authors": ["Tinsman AE", "Bellis TJ"], "date": "2021-12-07T00:00:00Z", "doi": "10.1002/ccr3.5175", "meta_date_publication": "2021 Dec", "meta_volume": "9", "meta_issue": "12", "meta_pages": "e05175", "score": 50250.906, "text_hl": "@DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@Overdose@@@ can result in @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular collapse@@@ and @DISEASE_Death @DISEASE_MESH:D003643 @@@death@@@. ", "citations": {"NLM": "Tinsman AE, Bellis TJ. Hyperinsulinemia/euglycemia and intravenous lipid emulsion therapy for the management of severe amlodipine toxicosis in a cat Clin Case Rep. 2021 Dec;9(12):e05175. PMID: 34934496", "BibTeX": "@article{34934496, title={Hyperinsulinemia/euglycemia and intravenous lipid emulsion therapy for the management of severe amlodipine toxicosis in a cat}, author={Tinsman AE and Bellis TJ}, journal={Clin Case Rep}, volume={9}, number={12}, pages={e05175}}"}}, {"_id": "31382228", "pmid": 31382228, "title": "Simultaneous estimation of amlodipine and atorvastatin by micelle-augmented first derivative synchronous spectrofluorimetry and multivariate analysis.", "journal": "Spectrochim Acta A Mol Biomol Spectrosc", "authors": ["Nasr JJ", "Shalan S"], "date": "2020-01-05T00:00:00Z", "doi": "10.1016/j.saa.2019.117430", "meta_date_publication": "2020 Jan 5", "meta_volume": "224", "meta_issue": "", "meta_pages": "117430", "score": 50249.793, "text_hl": "Five Selective, rapid and sensitive spectrofluorimetric methods were performed in this study for the simultaneous estimation of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@ (@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@AML@@@) and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ (@CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@ATR@@@) in their binary mixtures and combination polypills that are used for management of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular conditions@@@. ", "citations": {"NLM": "Nasr JJ, Shalan S. Simultaneous estimation of amlodipine and atorvastatin by micelle-augmented first derivative synchronous spectrofluorimetry and multivariate analysis. Spectrochim Acta A Mol Biomol Spectrosc. 2020 Jan 5;224():117430. PMID: 31382228", "BibTeX": "@article{31382228, title={Simultaneous estimation of amlodipine and atorvastatin by micelle-augmented first derivative synchronous spectrofluorimetry and multivariate analysis.}, author={Nasr JJ and Shalan S}, journal={Spectrochim Acta A Mol Biomol Spectrosc}, volume={224}, pages={117430}}"}}, {"_id": "39330938", "pmid": 39330938, "title": "Phase 1 Evaluation of the Bioequivalence and Drug-Drug Interaction Potential of a Novel Fixed-Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine.", "journal": "Clin Pharmacol Drug Dev", "authors": ["Lim HS", "Kim JH", "Hong JH", "Jung JG", "Sunwoo J"], "date": "2024-09-27T00:00:00Z", "doi": "10.1002/cpdd.1472", "meta_date_publication": "2024 Sep 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50247.977, "text_hl": "A fixed-dose combination (FDC) of @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ has been developed to improve medication adherence among @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@. ", "citations": {"NLM": "Lim HS, Kim JH, Hong JH, Jung JG, Sunwoo J. Phase 1 Evaluation of the Bioequivalence and Drug-Drug Interaction Potential of a Novel Fixed-Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine. Clin Pharmacol Drug Dev. 2024 Sep 27;():. PMID: 39330938", "BibTeX": "@article{39330938, title={Phase 1 Evaluation of the Bioequivalence and Drug-Drug Interaction Potential of a Novel Fixed-Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine.}, author={Lim HS and Kim JH and Hong JH and Jung JG and Sunwoo J}, journal={Clin Pharmacol Drug Dev}}"}}, {"_id": "39989148", "pmid": 39989148, "title": "Veno-arterial ECMO support for severe amlodipine toxicity combined with cardiogenic shock: A case report.", "journal": "Int J Artif Organs", "authors": ["Sun Y", "Wang T", "Xia J", "Hua L", "Cao S", "Zhang K"], "date": "2025-02-24T00:00:00Z", "doi": "10.1177/03913988251321620", "meta_date_publication": "2025 Feb 24", "meta_volume": "", "meta_issue": "", "meta_pages": "3913988251321620", "score": 50247.52, "text_hl": "We describe the case of a @SPECIES_9606 @@@patient@@@ with @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular collapse@@@ who successfully bridged to recovery from refractory @DISEASE_Shock @DISEASE_MESH:D012769 @@@shock@@@ secondary to severe @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@ as a result of ECMO and TPE treatment.", "citations": {"NLM": "Sun Y, Wang T, Xia J, Hua L, Cao S, Zhang K. Veno-arterial ECMO support for severe amlodipine toxicity combined with cardiogenic shock: A case report. Int J Artif Organs. 2025 Feb 24;():3913988251321620. PMID: 39989148", "BibTeX": "@article{39989148, title={Veno-arterial ECMO support for severe amlodipine toxicity combined with cardiogenic shock: A case report.}, author={Sun Y and Wang T and Xia J and Hua L and Cao S and Zhang K}, journal={Int J Artif Organs}, pages={3913988251321620}}"}}, {"_id": "37814541", "pmid": 37814541, "title": "Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial.", "journal": "J Cardiovasc Pharmacol Ther", "authors": ["Kim BJ", "Cha KS", "Cho WH", "Kim EJ", "Choi SH", "Kim MH", "Kim SH", "Park JB", "Park SM", "Sohn IS", "Ryu KH", "Chae IH"], "date": "2023-01-01T00:00:00Z", "doi": "10.1177/10742484231205204", "meta_date_publication": "2023 Jan-Dec", "meta_volume": "28", "meta_issue": "", "meta_pages": "10742484231205204", "score": 50246.75, "text_hl": "Efficacy and Safety of a Single-Pill Triple Combination of @CHEMICAL_olmesartan @CHEMICAL_MESH:C437965 @@@Olmesartan@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertensive@@@ Patients with Low-to-Moderate @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@Cardiovascular Risk@@@: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial.", "citations": {"NLM": "Kim BJ, Cha KS, Cho WH, Kim EJ, Choi SH, Kim MH, Kim SH, Park JB, Park SM, Sohn IS, Ryu KH, Chae IH. Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial. J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28():10742484231205204. PMID: 37814541", "BibTeX": "@article{37814541, title={Efficacy and Safety of a Single-Pill Triple Combination of Olmesartan, Amlodipine, and Rosuvastatin in Hypertensive Patients with Low-to-Moderate Cardiovascular Risk: A Multicenter, Randomized, Open-Label, Active-Control, Phase IV Clinical Trial.}, author={Kim BJ and Cha KS and Cho WH and Kim EJ and Choi SH and Kim MH and Kim SH and Park JB and Park SM and Sohn IS and Ryu KH and Chae IH}, journal={J Cardiovasc Pharmacol Ther}, volume={28}, pages={10742484231205204}}"}}, {"_id": "32246666", "pmid": 32246666, "title": "The gingival crevicular fluid levels of growth factors in patients with amlodipine-induced gingival overgrowth: A pilot study.", "journal": "Niger J Clin Pract", "authors": ["Kose KN", "Yilmaz S", "Noyan U", "Kuru B", "Yildirim HS", "Agrali OB", "Ozener HO", "Kuru L"], "date": "2020-04-01T00:00:00Z", "doi": "10.4103/njcp.njcp_532_19", "meta_date_publication": "2020 Apr", "meta_volume": "23", "meta_issue": "4", "meta_pages": "561-567", "score": 50246.46, "text_hl": "...BACKGROUND: @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, calcium channel blocker (CCB), is used in the management of @<m>DISEASE_Cardiovascular_Diseases</m> @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@ which causes @DISEASE_Gingival_Overgrowth @DISEASE_MESH:D019214 @@@gingival overgrowth@@@ (@DISEASE_Gingival_Overgrowth @DISEASE_MESH:D019214 @@@GO@@@). ", "citations": {"NLM": "Kose KN, Yilmaz S, Noyan U, Kuru B, Yildirim HS, Agrali OB, Ozener HO, Kuru L. The gingival crevicular fluid levels of growth factors in patients with amlodipine-induced gingival overgrowth: A pilot study. Niger J Clin Pract. 2020 Apr;23(4):561-567. PMID: 32246666", "BibTeX": "@article{32246666, title={The gingival crevicular fluid levels of growth factors in patients with amlodipine-induced gingival overgrowth: A pilot study.}, author={Kose KN and Yilmaz S and Noyan U and Kuru B and Yildirim HS and Agrali OB and Ozener HO and Kuru L}, journal={Niger J Clin Pract}, volume={23}, number={4}, pages={561-567}}"}}]}